Trial intelligence / Profile preview

Sirolimus vs Anti-VEGF for Wet AMD

NCT02357342Phase 2Completed

Sponsor
Raj K. Maturi MD
Start
Apr 2015
Primary completion
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sirolimus in exudative macular degeneration, sponsored by Raj K. Maturi MD. Started Apr 2015; status: completed.

02

Drugs

sirolimus
03

Conditions

exudative macular degeneration

Beyond the preview

Go deeper on NCT02357342.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02357342.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call